Agents de liaison de récepteur Fc de région constante d'immunoglobuline

• 收藏
• 分享

专利权人:

University of Maryland, Baltimore;Gliknik Inc.

发明人:

申请号：

EP13169230.3

公开号：

EP2641913B1

申请日:

2008.05.30

申请国别(地区):

EP

年份:

2018

代理人:

摘要：

IVIG replacement compounds are derived from recombinant and/or biochemical creation of immunologically active biomimetic(s). These replacement compounds are then screened in vitro to assess each replacements compound's efficiency at modulating immune function. Particular replacement compounds are selected for further in vivo validation and dosage/administration optimization. Finally, the replacement compounds are used to treat a wide range of diseases, including inflammatory and autoimmune diseases.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/